Cargando…
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Enterovirus 71 (EV71) is an aetiological agent responsible for seasonal epidemics of hand-foot-and-mouth disease, which causes considerable mortality among young children. Mucosal vaccines can efficiently induce secretory IgA at mucosal surfaces and thereby prevent or limit infection at the site of...
Autores principales: | Lin, Yu-Li, Chow, Yen-Hung, Huang, Li-Min, Hsieh, Szu-Min, Cheng, Pei-Yun, Hu, Kai-Chieh, Chiang, Bor-Luen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048030/ https://www.ncbi.nlm.nih.gov/pubmed/30013088 http://dx.doi.org/10.1038/s41598-018-28281-5 |
Ejemplares similares
-
Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
por: Lin, Yi-Wen, et al.
Publicado: (2013) -
Recombinant Human SCARB2 Expressed in Escherichia coli and its Potential in Enterovirus 71 Blockage
por: Vo-Nguyen, Hai-Vy, et al.
Publicado: (2021) -
A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71
por: Lin, Yu-Li, et al.
Publicado: (2020) -
Pathogenesis Study of Enterovirus 71 Using a Novel Human SCARB2 Knock-In Mouse Model
por: Jin, Yuefei, et al.
Publicado: (2021) -
miR‐127‐5p negatively regulates enterovirus 71 replication by directly targeting SCARB2
por: Feng, Chunhong, et al.
Publicado: (2017)